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At laboratory and clinical levels, therapeutic hypothermia has been shown to improve neurologic outcomes and mortality
following cardiac arrest. We reviewed each cardiac arrest in our community-based Veterans Affairs Medical Center over a three-
year period. The majority of cases were in-hospital arrests associated with initial pulseless electrical activity or asystole. Of a total
of 100 patients suffering 118 cardiac arrests, 29 arrests involved comatose survivors, with eight patients completing therapeutic
cooling. Cerebral performance category scores at discharge and six months were significantly better in the cooled cohort versus the
noncooled cohort, and, in every case except for one, cooling was offered for appropriate reasons. Mean time to initiation of cooling
protocol was 3.7 hours and mean time to goal temperature of 33◦C was 8.8 hours, and few complications clearly related to cooling
were noted in our case series. While in-patient hospital mortality of cardiac arrest was high at 65% mortality during hospital
admission, therapeutic hypothermia was safe and feasible at our center. Our cooling times and incidence of favorable outcomes
are comparable to previously published reports. This study demonstrates the feasibility of implementing, a cooling protocol a
community setting, and the role of neurologists in ensuring effective hospital-wide implementation.
1. Introduction
Comatose survivors of cardiac arrest notoriously have poor
outcomes including significant neurological deficits and
persistent vegetative state. Although there is variation in
incidence and outcomes, epidemiologic studies suggest that
between one and five of every 1,000 patients admitted to a
hospital in Western countries suffer an in-hospital cardiac
arrest [1], with the National Registry of Cardiopulmonary
Resuscitation citing an incidence of 0.175 events per bed in
a sample of American hospitals [2]. There is a wide range
of reported survival to hospital discharge, from 0% to 42%,
with larger studies approaching an average of 20% [1].
There is considerable evidence that mild therapeutic
hypothermia after cardiac arrest is protective in preventing
cerebral injury. Animal and human studies have demon-
strated that hypothermia reduces brain metabolism and thus
oxygen and ATP consumption [3, 4], reduces the release
of excitotoxic glutamate via regulation of transmembrane
electrolyte transport [5], protects against oxidative stress and
lipid peroxidation [6, 7], and alters gene expression (see
also reviews by Holzer [8], Liu and Yenari [9], and Yenari
et al. [10]) to promote brain cell survival after cerebral
ischemia. These physiologic effects were shown to have
clinical significance with the publication in 2002 of two
major clinical trials of therapeutic hypothermia in comatose
survivors of cardiac arrest. These studies, by Bernard and
colleagues [11] in Australia and by the Hypothermia after
Cardiac Arrest Study Group [12] in Europe, showed that
cooling these patients improved neurological outcomes and
reduced rate of death.
Since the publication of these trials, numerous medical
centers around the world have replicated the efficacy of
therapeutic hypothermia in this patient population and also
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established its overall feasibility and safety [13–15] (see also
review by Sagalyn et al. [16] and meta-analysis by Arrich
et al. [17]). Followup from the European multicenter trial
also included data from patients who had in-patient cardiac
arrests and patients who initially had pulseless electrical
activity (PEA) or nonventricular fibrillation or ventricular
tachycardia rhythms. While return of spontaneous circula-
tion (ROSC) was faster for in-hospital compared to out-
of-hospital patients, there was no statistically significant
difference in neurologic outcome or mortality in compar-
ing hypothermia or normothermia within the in-hospital
cohort. Within the PEA cohort, mortality was lower for
patients who received therapeutic hypothermia [18].
In spite of this growing body of literature, therapeutic
hypothermia has not been universally accepted and pursued
at all medical centers [19], with cited barriers including
lack of institutional protocols, resources, and limited prior
experience [20]. Some authors have called upon neurologists
to become more active in management of these patients
beyond offering prognosis and in helping create hospital-
wide policies given that therapeutic hypothermia remains
one of the only proven treatments for improving neurologic
outcome [21], and a recent report from Prior and colleagues
demonstrated the success of planning and implementing
a therapeutic hypothermia protocol in a community-based
hospital setting [20]. As such, in this retrospective analysis,
we report our experience with implementation of therapeu-
tic hypothermia for comatose cardiac arrest survivors and
its outcomes in an academically affiliated community-based
Veterans Affairs medical center in which the majority of
events were in-hospital.
2. Methods
The San Francisco Veterans Affairs Medical Center is a
378-bed hospital that serves more than 310,000 veterans
in Northern California. It is a teaching hospital affiliated
with the University of California San Francisco medical
center. The hospital is staffed 24 hours a day by an
inpatient neurology consultation service. In November 2007,
a protocol for mild therapeutic hypothermia after cardiac
arrest was written and reviewed by neurology attending
physicians at the medical center and was discussed with the
chiefs of the ICU services in December 2007. In February
2008, all housestaff and ICU nursing staff began in-service
training regarding appropriateness and implementation of
treatment including training on the use of cooling blankets
and devices, monitoring during protocol implementation,
and awareness of potential complications. Treating services
were asked to consult neurology service in cases where
therapeutic hypothermia was being considered.
This was a retrospective chart review study. In November
2007, a log was kept of every Code Blue on the medical
center campus including the Emergency Department. After
approval of study design from local IRB, each case was
retrospectively reviewed from November 2007 to August
2010. Initial demographic information including age, gender,
medical comorbidities, and events leading to the Code
Blue alarm was obtained for each case. In those cases of
documented cardiac arrest and loss of perfusing rhythm,
information regarding the code was obtained including
setting and location of the arrest; initial cardiac rhythm;
medical cause of arrest if known at time of event or
later; treatment during arrest including pharmacologic,
electrical, and surgical intervention; duration of code; time
at which spontaneous circulation returned; whether the
patient survived the code; presence of coma after arrest.
In those cases in which the patient was found to be in a
coma, the chart was reviewed to determine if neurology
service was consulted for possible cooling and any reason
why they were not consulted was noted. Appropriate cases
were reviewed for initiation of therapeutic hypothermia,
and reasons for not starting protocol were also recorded.
If started, the time of initiation in relation to return of
spontaneous circulation was recorded, as was the cooling
method, time at which goal temperature was achieved,
total duration of cooling, rewarming time, complications
related to cooling (defined as occurring during or up to
one week after completion of rewarming), and any technical
or unexpected difficulties were noted, including reasons
for early termination of protocol. The lowest temperature
recorded during treatment was also noted as measure of
possible hypothermia overshooting. Cerebral Performance
Categories (CPC) Scale scores of outcome (from 1 to 5, with
1 being conscious and alert with good cerebral performance,
2 being conscious with moderate cerebral disability, 3 being
conscious with severe disability and dependent on others
for activities of daily living, 4 being comatose or persistent
vegetative state, and 5 being brain death or death from other
causes) [22] were determined for all possible cases at hospital
discharge, and, where appropriate, at six-month and two-
year followup.
Inclusion criteria for initiation of cooling protocol
included age greater than or equal to 18, woman with
negative pregnancy test, and coma after cardiac arrest with
no eye opening or response to noxious stimulation after
resuscitation. Return of spontaneous circulation following
loss of perfusing rhythm and subsequent stable cardiac
rhythm was also required, with blood pressure greater than
90mmHg systolic. Any nonperfusing initial rhythm during
cardiac arrest including ventricular fibrillation, ventricular
tachycardia, PEA, or asystole was deemed appropriate for
treatment upon return of spontaneous circulation. Exclusion
criteria included noncomatose state or other reasons for
coma beyond cardiac arrest, pregnancy, known advanced
directive or goals of care that would preclude therapeutic
hypothermia and prolonged life support measures, and
known severe coagulopathy including administration of full
dose tPA during arrest or active bleeding. Cooling was
stopped if any of the exclusion criteria developed after
initiation.
Under the protocol, surface cooling—with ice packs
placed under the axilla and near the neck, torso, and limbs—
was initiated once patient was hemodynamically stable after
acute treatment for cardiac arrest and if there were no
other clear contraindications to initiation of hypothermia.
This was done to prevent delay in initiation of cooling.
The neurology consult service would then evaluate the
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patient and history and recommend whether cooling should
continue or be discontinued. If cooling was to be continued,
a cooling blanket or suit was deployed and nursing staff,
primary physicians, and neurology service would work
together to achieve goal temperature of 33◦C as quickly as
possible, ideally within 8 hours of return of spontaneous
rhythm. Temperature was then maintained at 32◦C to 33◦C,
and temperature sensing was done with a Foley catheter
bladder probe when possible, otherwise, rectal temperatures
were recorded. All patients were mechanically ventilated, and
midazolam and fentanyl were used for sedation. Vecuronium
was sometimes used as a paralytic and to help control
shivering, and EEG monitoring was placed if there was
concern for seizures under discretion of neurology consult
service. All other ICU management and treatment plans
were continued as deemed appropriate by the critical care
team. Twenty-four hours after initiation of therapeutic
hypothermia, passive rewarming was initiated using normal
blankets and the removal of cooling measures, with goal
of reaching 37◦C at a rate of 0.3–0.5◦C increase per hour.
Paralytics and then sedation would then be discontinued as
appropriate, and any subsequent hyperthermia was treated
with cooling blanket and antipyretics.
Fisher’s exact test and analysis of variance (ANOVA) were
used to look for significant differences across the cardiac
arrest groups including baseline demographics, mechanism
and duration of cardiac arrest, medical comorbidities, and
outcomes at discharge and six months. Within the cohort
of patients who completed cooling protocol, correlation
analysis between CPC score and time to initiation of
protocol and time to goal temperature after ROSC was
done by calculating Pearson’s correlation coefficient (r) and
the variance (r2). Total duration of cooling and time over
which rewarming was completed were also noted. All the
statistical analysis was performed using a computer software
program, R version 2.12.1 (The R Foundation for Statistical
Computing, 2010).
3. Results
From November 2007 to August 2010, there were 130 “Code
Blue” alerts at the San Francisco Veterans Affairs Medical
Center (see Figure 1). Of these, 12 of the alarms were done
in error or involved cases in which there was no loss of
a perfusing cardiac rhythm. Of the remaining 118 alerts
involving 100 patients, 38 cardiac arrests occurred in which
the patient did not survive. In these cases, the mean age
of the patients was 72 years and 97% of the patients were
men. Thirty-four arrests were in-hospital (89%) and the
initial cardiac rhythm was PEA or asystole in 95% of arrests,
with 5% ventricular tachycardia or fibrillation arrests. The
mechanism of arrest involved a primary pulmonary arrest in
8 arrests (21%), primary cardiac in 12 (32%), gastrointestinal
bleeding or catastrophe in 5 (13%), intraoperative event
in 2 (5%), sepsis or infection in 4 (11%), and unknown
or other etiology in 7 (18%). Comorbidities within this
cohort included coronary artery disease (CAD) or congestive
heart failure (CHF) in 17 patients (45%), cardiovascular
risk factors defined as hypertension, diabetes, dyslipidemia,
or tobacco use disorder in 21 (55%), cancer diagnosis in 9
(24%), pulmonary disease in 8 (21%), gastrointestinal bleed-
ing or end-stage liver disease in 7 (18%), end-stage renal
disease in 5 (13%), human immunodeficiency virus (HIV)
or hepatitis infection in 2 (5%), and history or ongoing
substance or alcohol abuse in 5 (13%).
Baseline demographics and characteristics of cardiac
arrest are summarized for the 80 cardiac arrests involving 70
unique surviving patients in Table 1. The overall mean age
of these cases was 70.7 years, and 95% were men. Ninety-
three percent of these arrests occurred in-hospital, and the
initial perfusing rhythm was PEA or asystole in 94% of cases
and ventricular tachycardia or fibrillation in 6%. Although
comparisons were limited by small sample size, return of
spontaneous circulation occurred faster in patients who were
not in a coma after arrest (F = 29.6, P = 3.9 × 10−9).
The 17 patients who were in a coma after arrest and did
not undergo therapeutic cooling also had a higher rate of
unfavorable CPC at discharge compared to the other groups
(P = 7.6 × 10−5) and between the comatose survivor
groups at six months after arrest (P = 0.05).
Amongst the 51 cardiac arrests in which the survivor
was not comatose afterwards, 14 were treated with attempted
electrical cardioversion (27%) and one patient received full-
dose tPA (2%). In one case, a chest tube was placed due
to hemothorax. Neurology was consulted in one case for
consideration of therapeutic hypothermia but patient was
noted to be moving extremities and was not comatose; the
service was consulted for six other patients later in their
hospital course typically for prognosis or management of
other complications. Of note, one patient was initially noted
to not be in a coma by primary team but was noted to be
comatose by neurology service 72 hours after arrest and has
since remained in persistent vegetative state.
Of the 18 cardiac arrests in which the survivor was
comatose but not cooled, one patient was treated with
attempted electrical cardioversion (6%) and three with full-
dose tPA (17%). One patient was taken to the operating
room urgently for cardiac surgery and was placed on extra-
corporeal membrane oxygenation. Neurology service was
consulted for five cases regarding initiation of therapeutic
hypothermia and two times for other reasons including
prognosis. The reasons why patients were not cooled are
listed in Figure 1. Of note, neurology was not called initially
by primary team for one patient due to prolonged duration
of code (30 minutes before ROSC); that patient was later
declared brain dead by neurology service. In addition, one
patient was felt to have a focal examination concerning for
focal cerebral process after cardiac arrest rather than global
hypoxia and so neurology service advised against cooling;
that patient remained neurologically devastated and was
eventually transitioned to hospice care and died one month
later.
Amongst the 11 cases where cooling was initiated, 3 were
treated with attempted electrical cardioversion (28%), and 2
were treated with bedside cardiac massage. Two were treated
with bedside cardiacmassage. Table 2 displays data specific to
this group of patients, including description of discharge and
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12 did not lose circulating rhythm
118 cardiac arrests
100 patients
38 patients
Did not survive code
11 patients
Hypothermia initiated
18 survivors not cooled
17 patients
8 completed protocol
Reasons cooling stopped:
1 due to coagulopathy
1 with change in goals of care
1 hemodynamically unstable
Reasons not cooled:
6 with change in goals of care
4 hemodynamically unstable
3 with severe coagulopathy
2 received full-dose TBA
1 neurology not consulted
1 placed on ECMO
1 neurology advised aganist
51 survived arrests,
not in documented
coma afterwards
42 patients
130 “Code Blue” alerts
110 patients
29 survived arrests,
in coma afterwards
28 patients
Figure 1: “Code Blue” Alerts at San Francisco VA Medical Center from November 2007 to August 2010. The diagram breaks down the
numbers and types of “Code Blue” arrests including brief categorization of reasons of why patients who were comatose after cardiac arrest
were not cooled or why cooling was stopped after initiation.
six-month outcomes and details regarding cessation of cool-
ing therapy in three cases. For the 8 patients that completed
the cooling protocol, mean time to initiation of cooling
protocol was 3.7 hours (range 2 to 6 hours) and mean time
to goal temperature of 33◦C after ROSC was 8.8 hours (range
3 to 17 hours). Cooling was continued for an average of 23.6
hours (range 22 to 24 hours). Rewarming occurred over an
average of 13.9 hours (range 4 to 24 hours). Five of these
8 patients had favorable CPC score of 1 or 2 after 72-hour
evaluation (63%) and three expired before discharge (38%).
Three patients continued to have CPC score of 1 or 2 at
six months after cardiac arrest (38%). Complications noted
during therapeutic cooling or during the subsequent week
after cardiac arrest included cardiac arrhythmia requiring
treatment with medication in 3 patients (38%), pneumonia
in 3 patients (38%), another infection in 1 patient (13%),
and deep venous thrombosis or subsegmental pulmonary
embolus in 2 patients (25%). There were no instances of
acute kidney injury, skin breakdown or rash, or bleeding or
hemorrhage during this same time period.
Neither the time to initiation of cooling protocol (r =
0.48, r2 = 0.23) nor the time to goal temperature of 33◦C
(r = 0.05, r2 = 0.003) was associated with CPC scores at
discharge.
4. Discussion
We report our experience of therapeutic cooling in comatose
survivors at our academically affiliated community-based
Veterans Affairs medical center. We show that it is possible to
implement such a cooling protocol in this setting where the
majority of arrests occurred in hospital. Of the patients who
completed the therapeutic hypothermia protocol, 63% (5 of
8) had a favorable neurologic outcome at the time of hospital
discharge. Although this is a small sample size, this rate is
similar to those reported in the original trials (49% and 55%)
[11, 12] and in subsequent series [20]. This percentage of
favorable outcomes is also consistent with larger registries
that have noted that 60 to 85% of patients who survive in-
hospital arrests tend to have a favorable neurologic outcome
[2, 23].
In terms of the initiation of the cooling protocol from
time of ROSC, our average of 3.7 hours is comparable to
another series from a community hospital [20] and the
average time to goal temperature of 8.8 hours was also
comparable to previous reports, which ranged from 5.0
to 9.2 hours [15, 18, 20]. Given that most of the arrests
were in-hospital, it would be hoped that time to initiation
would be even shorter. However, there was no association
with time from ROSC to initiation of protocol or time to
goal temperature and CPC score at discharge, although the
small sample size likely contributed to the lack of statistical
significance.
In comparing the survivors of cardiac arrest, there
was a significantly faster ROSC in the cases where the
survivor was not in a coma afterwards. Although this data
was not available in all cases, faster return of circulating
rhythm was also associated with higher probability for
favorable CPC given that more patients who were not
in a coma were neurologically intact at discharge and at
six months compared to the patients who were comatose.
Although these noncomatose survivors were similar in age
and comorbidities, and had high rates of initial PEA or
asystole during arrest compared to the comatose survivors,
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Table 1: Characteristics of cardiac arrests in which patient survived.
Not in coma after arrest
(n = 51 arrests, 42
patients)
In coma after arrest, not
cooled (n = 18 arrests,
17 patients)
In coma after arrest,
cooling started (n = 11
arrests, 11 patients)
Statistical test for
significance
Sex
Male 40 (95) 17 (100) 10 (91) P = 0.53e
Age, in yrs 70.4 ± 11.1 72.4 ± 12.4 69.5 ± 13.0 F = 0.24, P = 0.79f
In-hospital Arrest 47 (92) 16 (94) 11 (100)
Initial cardiac rhythm
PEA/asystole 47 (92) 18 (100) 10 (91)
P = 0.51e
VTach/VFib 4 (8) 0 (0) 1 (9)
ROSC in minutes
5.2 ± 4.6 range
(0.1–20)a
33.5 ± 21.2 range
(5–60)b
21.9 ± 11.9 range
(5–35)c
F = 29.6, P < 0.001f
Mechanism of arrest
1◦ Cardiac 24 (47) 4 (22) 2 (18) P = 0.07e
1◦ Pulmonary 13 (25) 8 (44) 3 (27) P = 0.33e
1◦ Gastrointestinal 1 (2) 2 (11) 1 (9) P = 0.18e
Sepsis/infection 5 (10) 2 (11) 0 (0) P = 0.72e
Intraoperative 2 (4) 2 (11) 0 (0) P = 0.30e
Unknown/other 6 (12) 0 (0) 5 (45) P = 0.005
Comorbidities
CAD or CHF 24 (57) 9 (53) 7 (64) P = 0.83e
Vascular RFs 26 (62) 13 (76) 6 (55) P = 0.47e
Cancer 8 (19) 5 (29) 3 (27) P = 0.66e
Pulmonary disease 8 (19) 3 (18) 1 (9) P = 0.91e
GI/liver 5 (12) 2 (12) 1 (9) P = 1.0e
ESRD 6 (14) 3 (18) 0 (0) P = 0.41e
HIV, hepatitis 3 (7) 1 (6) 0 (0) P = 1.0e
Substance abused 3 (7) 1 (6) 2 (18) P = 0.48e
Expired before discharge 13 (31) 16 (94) 6 (55) P < 0.001e
CPC at discharge
Favorable (1-2) 27 (64) 1 (6) 5 (45)
P < 0.001e
Unfavorable (3–5) 15 (36) 16 (94) 6 (55)
CPC at 6 Months
Favorable (1-2) 19 (45) 0 (0) 3 (27)
P = 0.001e
Unfavorable (3–5) 23 (55) 17 (100) 8 (73)
Values as whole number and (percentage), except in case of continuous variable, given as mean ± standard deviation.
ROSC: return of spontaneous circulation; 1◦: primary; VTach, ventricular tachycardia; VFib: ventricular fibrillation; vascular RFs: cardiovascular risk factors.
Values as whole number and (percentage), except in case of continuous variable, given as mean ± standard deviation.
aData available for 34 of 51 arrests; bavailable for 10 of 18 arrests; cavailable for 8 of 11 arrests; dsubstance abuse includes alcohol abuse; eFisher’s exact test;
f analysis of variance (ANOVA).
there was a trend towards a higher proportion of primary
cardiac etiologies (P = 0.07). Similarly, only one patient
out of 18 arrests in the noncooled comatose survivor group
was treated with electrical cardioversion, compared to more
than 25% of the arrests in the noncomatose and cooled
comatose survivor groups, suggesting increased evolution
of rhythm to ventricular fibrillation or tachycardia in these
latter arrests. Thus, there were some differences in the
baseline characteristics in these patient groups which likely
affected the duration of arrest. This also meant that, as
expected, patients with longer periods of impaired cerebral
perfusion were more likely to become comatose.
We should also point out that, within this sample, 38
patients did not survive the arrest itself and overall 65
patients (65%) died before hospital discharge. This rate is
higher than reported in previous registries of in-hospital
cardiac arrest [1, 2] and may be related to the large majority
of patients having an initial rhythm at time of arrest of PEA
or asystole (94% overall), which is associated with poorer
outcome and has been noted to be the predominant initial
6 Stroke Research and Treatment
Table 2: Comatose survivors of cardiac arrest that were treated with therapeutic hypothermia.
Patient
no.
Date of
arrest
Age
Mechanism of
arrest
Duration
pulseless
Time to
initiation
Time
to 33◦C
Time
cooled
Lowest
temp.
Rewarming
time
Comments/CPC at discharge
1 11/22/2007 55
Suicide
attempt,
hanging
35mins 3.5 hrs 11 hrs 24 hrs N/A 16 hrs
At 72 hrs, intact brainstem
reflexes but persistent coma, care
withdrawn (CPC 5)
2 1/26/2008 83 Unknown 20mins — — — — —
Cooling stopped when goals of
care changed after family arrived;
died next day (CPC 5)
3 5/2/2008 59
Variceal
bleeding,
aspiration
20mins — — — — —
Cooling stopped due to
coagulopathy and severe GI
bleeding; died next day (CPC 5)
4 5/27/2008 85 Aspiration 30mins 6 hrs 9 hrs 24 hrs 32.1◦C 12 hrs
Neurology called late due to
concern for coagulopathy;
persistent coma at 72 hrs; care
withdrawn a week later (CPC 5)
5 7/27/2008 83
Cardiac
Arrhythmia
35mins 2 hrs 6 hrs 23 hrs 31.3◦C 24 hrs
Discharged to rehab unit with
short-term memory deficits,
required assistance with walking
(CPC 2); later diagnosed with
gastric cancer, deceased 8
months later
6 8/20/2008 61
Pericardial
tamponade
N/A 4 hrs 9 hrs 24 hrs 32.4◦C 9 hrs
Initially treated in OR for
tamponade; at 72 hrs in
persistent coma with myoclonic
status epilepticus; ethics consult
called and care withdrawn (CPC
5)
7 2/21/2009 57
Hyperkalemia,
postextubation
N/A 4 hrs 6 hrs 22 hrs 33.0◦C 10 hrs
At 72 hr exam, neurologically
normal examination; discharged
to rehab. unit, still alive and
neurologically intact (CPC 1)
8 2/24/2009 85
Possible vagal
hyperactivity
5mins 2.5 hrs 3 hrs 24 hrs 32.3◦C 14 hrs
At 72 hrs, awake and alert,
neurologically intact aside from
mild confusion (CPC 2); had
another arrest 3 weeks later and
died
9 5/29/2009 59
Pulmonary
embolus,
sepsis
5mins 0.5 hrs 4 hrs 5 hrs N/A —
Cooling stopped due to
persistent hypotension and
multiorgan failure; deceased two
days later (CPC 5)
10 2/20/2010 78
COPD,
aspiration
N/A 5 hrs 9 hrs 24 hrs 30.5◦C 22 hrs
At 96 hrs, alert, briskly following
commands; remained ventilator
dependent, transferred to rehab.
unit (CPC 2); died 6 months
later
11 8/10/2010 59 Unknown 25mins 2.5 hrs 17 hrs 24 hrs 32.0◦C 4 hrs
Myoclonus while cooled;
rewarming occurred quickly and
febrile afterwards; despite
normal neuroexamination at
72 hrs; discharged to home, still
alive (CPC 1)
rhythm in other in-hospital arrest series as well [24, 25].
Among patients who received cooling, 2 died within the
following six months (18%). These observations are also
in line with a recent study that demonstrated decreased
chances of good outcome from cooling in patients with such
nonshockable rhythms [26]. It is possible that patients in
the latter category may have more severe disease, but this
study did not suggest that such patients were harmed by
cooling.
Of the 18 cases in which the survivor was comatose and
therapeutic hypothermia was not initiated, these patients
were not felt to be candidates for therapeutic hypothermia
due to change in goals of care status, hemodynamic insta-
bility, or severe coagulopathy and hemorrhage. There were 2
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cases where patients might have benefitted from cooling and
neurology was not consulted initially. These cases occurred
before a formal cooling protocol was adopted by our hospital
and relevant staff were educated in its implementation. Since
staff training occurred, no further cases were identified.
Moving forward, one way to prevent this in the future would
be to have every case in which the patient was comatose after
cardiac arrest discussed with the on-call neurologist, even in
cases where there is a clear contraindication. Other measures
to improve our current protocol might include providing a
dedicated neurology code pager in code blue protocols and
staff training and reorientation at regular intervals.
At our institution, hypothermia was instituted using
surface cooling methods and cooling blankets or suits. While
our time to target temperature was comparable to previously
published studies, it might be possible to further shorten the
cooling time by induction with chilled intravenous saline
solution. Further, there has also been some concern that
surface cooling has been associated with overshooting of
goal temperatures which could lead to higher complication
rates. Studies have shown that endovascular catheter-assisted
hypothermia allows for better control of temperature and
faster cooling rates [27]. As such, the incorporation of
endovascular cooing catheters might help achieve cooling at
a faster rate and prevent overshooting of mild hypothermia
goals. However, placement of these catheters requires a
trained physician and this can often delay the initiation
of cooling if the physician is not readily available [28].
Many community hospitals, including ours, do not always
have such trained individuals on staff. Thus, our experience
demonstrates that it is still possible to implement a cooling
protocol where advanced technologies are not available. It
should be noted that, in our series, there were two cases of
overshooting beyond 32◦C but both of these patients had a
favorable CPC score at discharge.
Complications that were noted during the cooling phase
and in the week after induction of hypothermia included
pneumonia, cardiac arrhythmia requiring administration
of medication, deep venous thrombosis, and, in one case,
subsegmental pulmonary embolus. It is unclear whether
these complications were necessarily related to cooling,
as these are also common complications that occur in
noncooled cardiac arrest patients. However, a recent study of
therapeutic cooling in stroke patients did report a somewhat
higher incidence of pneumonia that did not adversely affect
eventual patient outcome [29]. Our rates were similar to
those described by Prior and colleagues in their series at a
community-based hospital [20]. There were no complica-
tions associated with rewarming, and although one patient
was warmed faster than expected, this was likely related to
underlying fever leading to rapid increase in temperature
once therapeutic hypothermia was completed.
Limitations of this study are largely related to the
retrospective nature of this analysis. Some data points were
not recorded in each case, and determination of timing
often involved estimates based on ICU nursing charting
and by extrapolating from time of arrest indicated by
treating physicians. The objective of this study was not to
show evidence of the efficacy of therapeutic hypothermia
which has been well established but the implementation of
a cooling protocol in this particular hospital setting. The
lack of a true control group makes it difficult to interpret
the overall significance of therapeutic hypothermia beyond
comparison of results with previous trials. Although there
were patients who were comatose and not cooled, the
baseline characteristics of these arrests and the fact that they
were actively not cooled precludes direct comparison with
the patients who were cooled.
5. Conclusion
This work describes our experience over the last three
years with therapeutic hypothermia for comatose survivors
of cardiac arrest. In contrast to previous reports, the vast
majority of our arrests occurred in-hospital, the initial
rhythm was PEA or asystole, and many of these patients
died prior to hospital discharge. With the exception of 2
cases, therapeutic hypothermia was appropriately started
for patients who were comatose and had no contraindi-
cation to cooling and the rate of favorable CPC scores at
hospital discharge were comparable in our small series to
previous reports and the original landmark trials. Clearly,
the mortality of in-hospital cardiac arrest is high but we
were able to offer a treatment where prior clinical trials
showed clear benefit in terms of neurologic recovery. We
describe our experience with this treatment which was
readily implemented and completed. Reviewing these cases
will also help in improving our protocols in the future
and demonstrate the role of neurologists in initiating and
managing therapeutic hypothermia.
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